Injective (INJ) is showing renewed bullish momentum, recovering from a sharp midweek sell-off and moving back toward the $8.00 level. The token is trading near $7.93, based on available market data, after rebounding from a recent low of approximately $6.41. Compared with its closing price of $7.68 at the beginning of the week, INJ has gained roughly 3.3%. However, the recovery has not fully erased the losses recorded earlier in the period, leaving the token at a technically important turning point.
One factor supporting the positive outlook is Injective’s reported improvement in protocol revenue. Recent market analysis highlighted that the network had entered the top 10 protocols by 30-day revenue, a development that could strengthen confidence in its economic activity and utility. INJ has also shown relative strength compared with Bitcoin in the latest available market snapshot, suggesting that buying interest may not be driven solely by the broader market’s movement. Nevertheless, sustained revenue growth and continued demand will be important if the token is to maintain its recovery.
Crypto analyst Ali Martinez has identified a potential bullish setup in INJ based on a cup-and-handle pattern. Martinez previously highlighted the $7.33 neckline as a critical level and suggested that a successful continuation of the pattern could open a path toward $13.40. This target remains a conditional technical scenario rather than a confirmed forecast. INJ is currently trading above the cited neckline, but further price action is needed to determine whether the bullish structure can develop as anticipated.
On the downside, the $7.72–$7.79 zone represents an important near-term support area. Holding above this range could preserve the recovery and allow buyers to challenge nearby resistance levels. If INJ falls below $7.72, the price could retreat toward $7.62. A deeper correction could bring the $7.45–$7.50 region into focus, followed by the broader $7.20–$7.35 area, where previous price action and the identified cup-and-handle neckline may become relevant.
On the upside, $7.94 is the immediate resistance level, followed by the psychological $8.00 threshold. A sustained move above this area could expose the $8.19–$8.32 zone, which includes recent trading highs. A convincing close above this resistance region, supported by stronger trading volume, would improve the bullish outlook and suggest that buyers are regaining control. Failure to break through these levels, however, could leave INJ vulnerable to further consolidation.
Overall, Injective’s short-term outlook is cautiously bullish but remains dependent on confirmation. The weekly gain of approximately 3.3%, the rebound from its recent low and the reported improvement in protocol revenue offer constructive signals. However, the token needs to maintain support around $7.72–$7.79 and overcome resistance between $8.00 and $8.32 to strengthen its recovery. A break below $7.72 would weaken the immediate outlook, while a sustained move above $8.32 could open the way for a broader rebound. These levels are technical reference points rather than guaranteed price outcomes, and the analysis does not constitute investment advice.
